Elite in Major Depression

Gustavo Turecki

6875 LaSalle Blvd, 
Verdun, CA 
Elite in Major Depression
6875 LaSalle Blvd, 
Verdun, CA 
OverviewLocationsClinical Research

Overview

Gustavo Turecki practices in Verdun, Canada. Mr. Turecki is rated as an Elite expert by MediFind in the treatment of Major Depression. His top areas of expertise are Major Depression, Bipolar Disorder (BPD), Schizophrenia, and Lesch-Nyhan Syndrome.

His clinical research consists of co-authoring 522 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 52 articles in the study of Major Depression.

Gender
Male

Locations

6875 LaSalle Blvd, Verdun, Canada
Other Locations
6875 LaSalle Boulevard, H4H 1R3, Verdun, QC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Artificial Intelligence in Depression - Medication Enhancement: A Randomized, Patient and Rater Blinded, Active-Controlled Trial of a Hybrid-Classic/Machine-Learning Enabled Clinical Decision Aid for Personalized and Individualized Pharmacological Depression Treatment Selection
Artificial Intelligence in Depression - Medication Enhancement: A Randomized, Patient and Rater Blinded, Active-Controlled Trial of a Hybrid-Classic/Machine-Learning Enabled Clinical Decision Aid for Personalized and Individualized Pharmacological Depression Treatment Selection
Enrollment Status: Completed
Publish Date: January 30, 2024
Intervention Type: Device
Study Phase: Not Applicable
Investigations on the Efficacy of Ketamine in Depression in Comparison to Electroconvulsive Therapy
Investigations on the Efficacy of Ketamine in Depression in Comparison to Electroconvulsive Therapy
Enrollment Status: Suspended
Publish Date: September 01, 2023
Intervention Type: Procedure, Drug
Study Drug: Ketamine
Study Phase: Phase 3
View 1 Less Clinical Trial

522 Total Publications

Genome-wide association study of borderline personality disorder identifies 11 loci and highlights shared risk with mental and somatic disorders.
Genome-wide association study of borderline personality disorder identifies 11 loci and highlights shared risk with mental and somatic disorders.
Journal: medRxiv : the preprint server for health sciences
Published: August 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Turecki's expertise for a condition
ConditionClose
    View All 20 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile